Tomoregulin
Tomoregulin | |
---|---|
Script error: No such module "InfoboxImage". | |
Identifiers | |
Symbol | ? |
Tomoregulin, also known as transmembrane protein with EGF-like and two follistatin-like domains 2 (TMEFF2), is a protein encoded by the TMEFF2 gene in humans. This protein is primarily expressed in the brain and prostate and has been implicated in various physiological and pathological processes, including neuroprotection and prostate cancer.
Structure[edit | edit source]
Tomoregulin is a type I transmembrane protein characterized by the presence of an extracellular domain containing one EGF-like domain and two follistatin-like domains. The protein also has a single transmembrane domain and a short cytoplasmic tail. The EGF-like domain is involved in protein-protein interactions, while the follistatin-like domains are thought to play a role in binding to transforming growth factor-beta (TGF-β) family members.
Function[edit | edit source]
Tomoregulin is involved in several biological processes:
- Neuroprotection: In the central nervous system, tomoregulin has been shown to have neuroprotective effects. It may play a role in protecting neurons from apoptosis and oxidative stress.
- Prostate Cancer: Tomoregulin is highly expressed in the prostate and has been studied for its role in prostate cancer. It is considered a potential biomarker for prostate cancer diagnosis and prognosis. The protein may influence cancer cell proliferation and survival.
- Cell Signaling: Through its EGF-like and follistatin-like domains, tomoregulin is involved in modulating cell signaling pathways, including those mediated by TGF-β.
Clinical Significance[edit | edit source]
Tomoregulin's expression pattern and functional roles make it a candidate for therapeutic targeting in diseases such as prostate cancer and neurodegenerative disorders. Research is ongoing to understand its potential as a biomarker and therapeutic target.
Research[edit | edit source]
Studies have focused on the role of tomoregulin in cancer biology, particularly in prostate cancer. Its expression levels have been correlated with disease progression, and it is being investigated as a target for novel cancer therapies. Additionally, research into its neuroprotective properties is exploring its potential in treating neurodegenerative diseases.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD